Skip to content
ALL Metrics
-
Views
68
Downloads
Get PDF
Get XML
Cite
Export
Track
Systematic Review

A scoping review of infertility research conducted in the Republic Of Ireland

[version 1; peer review: 1 approved]
PUBLISHED 24 Apr 2024
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background

Approximately 25 million citizens in Europe experience infertility. Until September 2023, the Republic of Ireland (RoI) was the only state in the European Union that did not offer any state-funded access to Assisted Reproductive Technology (ART). As research supports the understanding, and improvement, of care delivery, and research activity is associated with healthcare performance, it seems timely to develop an understanding of infertility research to-date in RoI. The aim of this scoping review was to examine the extent and nature of research on infertility conducted in RoI.

Methods

A protocol for this scoping review was published through the Open Science Framework (https://doi.org/10.17605/OSF.IO/H8F4Y) in March 2023. The search strategy was comprised of electronic searches, review of reference lists, grey literature searches, and screening of publications from the European Society of Human Reproduction and Embryology and the International Committee for Monitoring Assisted Reproductive Technologies. Studies focused on infertility or infertility care that were conducted in RoI were included. Deductive content analysis was used to cluster studies.

Results

In total, 105 studies were included and published between 1951 and 2023, with a marked increase from 2010. Studies most frequently considered Success Rates of ART (31.4%), Service Description and Evaluation (12.4%), and Optimising Treatment Regimes or Protocols (11.4%).

Conclusions

The sizable body of research is congruent with the increasing burden of infertility. However, the literature is limited by a predominant focus on ART success rates, a dearth of qualitative studies, limited engagement with healthcare providers, and limited exploration of the quality of care provision. This review may offer a useful model for researchers in other countries. The variability in availability, and outcomes, of ART across Europe conveys the necessity of understanding and advancing research within individual countries and health systems as well as internationally.

Keywords

Infertility, IVF, In-vitro Fertilisation, Fertility Treatment, Fertility Care, Assisted Reproduction, Assisted Reproductive Technology, Ireland

Introduction

Infertility was recognised as a priority global public health challenge for 20231. In Europe, 25 million citizens are estimated to experience infertility2. Infertility is associated with a number of negative outcomes including reduced quality of life3, symptoms of depression and anxiety4, and an increased frequency of sexual and psychological problems5. There are also significant financial impacts for those who engage with Assisted Reproductive Technology (ART)6. Where fertility treatment is accessed, patients often perceive the quality of care to be suboptimal7 and the psychological impact of infertility, along with an impact of treatment failures, continues to be felt8.

Until the initiation of state-funded fertility services in September 20239, the Republic of Ireland (RoI) was the only European Union state that did not offer any state-funded access to ART2,10. The RoI also lacks ART legislation and a national registry of ART activity2,11. Accordingly, it has been ranked 40th of 43 European countries, and rated as ‘exceptionally poor’, according to the European Fertility Atlas which considers both legal access to treatments and funding of these2. These issues have sometimes resulted in the explicit non-consideration of RoI within infertility research or the inclusion of limited data. As a result, it is difficult to establish what is known about infertility in RoI but it is reasonable to suggest that the impact of infertility on, and the provision of infertility care to, persons in RoI may differ to that of patients in countries where fertility care is more accessible and well-established.

As state-funded ART services are introduced for the first time9, it seems timely to develop an understanding of infertility research activity, and outcomes, to-date in RoI. Research can yield an understanding of, and contribute to improving, many crucial aspects of the provision of infertility-related care (e.g., treatment efficacy, treatment costs, patient experience). Further, there is a clear association between clinicians’ and organisations’ engagement in research and healthcare performance (e.g., improved patient outcomes)12,13 and understanding and encouraging research activity in healthcare organisations and settings is therefore recommended. The current scoping review examines the extent and nature of research on infertility conducted in RoI. Scoping reviews have become a popular means of synthesising evidence from health research14, and can play an important role in shaping future research agendas14. Accordingly, the review may function to support the improvement of infertility care provision in RoI and ensure that future research contributes usefully. This review may also offer a model for synthesising and planning infertility research elsewhere. There continues to be substantial variability in availability of ART services, and their outcomes across Europe15. Such data convey the necessity of understanding and advancing research within individual countries, contexts, and health systems as well as internationally.

Methods

This review was conducted as per the JBI methodology for scoping reviews16 and is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews (PRISMA-ScR)17. A review protocol was published through the Open Science Framework (https://doi.org/10.17605/OSF.IO/H8F4Y) in March 2023, and Extended Data 118 details minor revisions made to the methodology subsequently.

Search strategy

The search strategy had four components. First, electronic searches were conducted across five electronic databases in March 2023: Medline, CINAHL, Academic Search Complete, PsycInfo, and Psychology and Behavioural Sciences Collection. The development of the search strategy was supported by a Research Librarian. The search strategy (for Medline search strategy, see Table 1) consisted of subject headings along with free-text keywords and was adapted as necessary for use across the different databases. Second, the reference lists of all studies identified as eligible for inclusion were screened to identify additional eligible articles. Third, searches were undertaken across ProQuest, Google (first 100 returns for each search, location set to Ireland), and Google Scholar (first 100 returns for each search, location set to Ireland) to identify relevant grey literature. Finally, in recognition of the inclusion of Irish data on ART success rates in international reports, the list of publications from the European Society of Human Reproduction and Embryology (ESHRE) and the International Committee for Monitoring Assisted Reproductive Technologies (ICMART) were screened.

Table 1. Search strategy for this review as implemented on medline.

1. Exp fertility/
2. Exp infertility/
3. Infertil*.mp
4. Fertil*.mp
5. Exp infertility, male/
6. Exp infertility, female/
7. Sub?fertil*.mp.
8. Fecund*.mp
9. Sub?fecund*.mp
10. In?fecund*.mp
11. Steril*.mp
12. Childless*.mp
13. Reproduct*.mp
14. Exp fertilization in vitro/
15. Exp fertility clinics/
16. IVF.mp
17. ICSI.mp
18. IUI.mp
19. (Intrauterine adj1 insemination).mp
20. (In vitro adj1 fertili#ation).mp
21. (In-vitro adj1 fertili#ation).mp
22. (Intra?cytoplasmic adj1 Sperm adj1 Injection).mp
23. (Assist* adj1 reproduct*).mp
24. 1-23/OR
25. exp Ireland/
26. (eire or irish or Ireland).mp
27. 25 OR 26
28. 24 AND 27
29. limit 28 to English language

Study selection

Inclusion and exclusion criteria. In order to be included, studies were required to have a primary focus on infertility or infertility care, to be written in English, and to have been conducted in RoI. Eligible studies could include persons experiencing infertility or healthcare professionals or institutions that provide treatment to persons experiencing infertility.

Studies were excluded if they: a) were solely laboratory-based with no clinical data (e.g., pregnancy rates) presented; b) related to pregnancy loss without a focus on persons experiencing infertility; c) related to contraception or family planning, pregnancy, and termination of pregnancy; d) were solely concerned with the genetic components of infertility; e) were conducted in countries other than RoI, did not explicitly state where data was collected, or presented data from RoI alongside data from other countries and it was not possible to extract RoI-specific data; e) did not report original research or were only available as a conference abstract; f) consisted of a case report or a series of these, or; g) focused on fertility preservation for cancer patients.

Screening. Titles and abstracts of records returned during the electronic searches were exported to Endnote© (https://endnote.com/; Zotero (https://www.zotero.org/) may be considered as a free alternative that can perform equivalent functions) for removal of duplicates and recordkeeping. The screening of all records was conducted in duplicate using Microsoft Excel© (https://www.microsoft.com/en-ie/microsoft-365/excel; Google Sheets (https://www.google.com/sheets/about/ may be considered as a free alternative that can perform equivalent functions). Where eligibility was unclear, full-texts were reviewed. For papers where inclusion was unclear, or in instances where two reviewers differed, the wider research team was consulted. A careful record was maintained to document the review of full-texts and primary reasons for exclusion, as relevant.

Data extraction. For each study, data were extracted by two independent reviewers on study aim, design (categorised as either quantitative, qualitative, mixed or multiple methods), methodology, participants, setting, measures, and key findings into a data extraction tool presented within Microsoft Word© (https://www.microsoft.com/en-ie/microsoft-365/word; Google Docs (https://www.google.com/docs/about/) may be considered as a free alternative that can perform equivalent functions). The data extraction tool was developed as per Pollock et al.19’s guidance on best practice for data extraction, analysis, and presentation within scoping reviews. The tool was piloted across five studies. Any disagreements in data extraction were resolved through discussion.

Data synthesis. Narrative synthesis, as described by Popay et al.20, was undertaken to collate the extracted data. Deductive content analysis21 was also used to cluster studies by area of research. Specifically, the researchers worked together to consider the data extracted for each study and to categorise its research area. An initial list of infertility-related research areas was developed using the research priorities reported within Garcia et al.22 and Duffy et al.23. These initial codes were refined, and added to, by the researchers to reflect the diversity and foci of included studies. Ultimately, thirteen distinct research areas (see Table 2) were used to cluster studies.

Table 2. Research areas used to cluster studies identified within the current review.

Research Arean of Included Studies (%)
Safety of Treatments (side-effects)2 (1.9%)
Psychosocial wellbeing during infertility7 (6.7%)
Healthy Habits including diet and exercise2 (1.9%)
Success rates of ART33 (31.4%)
Risks associated with ART4 (3.8%)
Alternative and supplemental treatments5 (4.8%)
Gamete quality and ovarian reserve3 (2.9%)
Causes of Infertility2 (1.9%)
Service Description and Evaluation13 (12.4%)
Ethics, Access, and Organisation of Care9 (8.6%)
Quality of Service Provision3 (2.9%)
Optimising treatment regimes or protocols12 (11.4%)
Exploring factors that may predict treatment outcomes.10 (9.5%)

Note. The initial list of infertility-related research areas was developed using the research priorities reported within Garcia et al.22 and Duffy et al.23 and refined by the research team.

Results

Figure 1 presents a PRISMA flow diagram for this review. Ultimately, 107 documents reporting 105 distinct studies, published between 1951 and 2023, were included. A full list of included studies is presented in Extended Data 218. A summary of the characteristics of the 105 included studies is presented in Table 3, and a study-by-study summary is presented in Extended Data 318.

df027ff5-1e6f-42bf-a424-3f322da761de_figure1.gif

Figure 1. PRISMA flow diagram.

Table 3. Summary of the characteristics of included studies (n=105).

Characteristicn of Studies (%)
Year of Publication
Pre-19907 (6.7%)
1990–19945 (4.8%)
1995–19998 (7.6%)
2000–20048 (7.6%)
2005–200914 (13.3%)
2010–201427 (25.7%)
2015–201922 (21.0%)
2020-Present14 (13.3%)
Study Design
Quantitative98 (93.3%)
Qualitative3 (2.9%)
Mixed Methods4 (3.8%)
Participants providing data*
Infertile Women32 (30.5%)
Infertile Men8 (7.6%)
Men and Women experiencing Infertility or Infertile Couples26 (24.8%)
Fertility clinics34 (32.4%)
Healthcare Professionals2 (1.9%)
Children conceived via ART3 (2.9%)
Other (e.g., embryos)2 (1.9%)

Note. Percentages do not total to 100% in this category as some studies included participants from more than one category. ART= Assisted Reproductive Technologies.

Safety of treatments

Two studies (1.9%) considered the safety of ART-related treatments. One study24 identified oestradiol levels (15,000 pmol/L) and number of oocytes (≥20) that were predictive of hospital admissions for ovarian hyperstimulation syndrome. The other assessed the effects of a mixture of fentanyl and midazolam as analgesia during oocyte retrieval.

Psychosocial wellbeing during infertility

Seven studies (6.7%) examined psychosocial wellbeing during infertility. For instance, one study25 explored whether psychological stressors were related to ART outcomes and found no differences in wellbeing, support, or stress among those who conceived versus those who did not. Walsh et al.26 explored anxiety and readiness around potential twin pregnancies. Three of the studies2729 engaged exclusively with men experiencing infertility, examining how it impacted their psychological wellbeing and exploring factors predictive of distress. One study28 revealed a negative impact of male factor infertility on sense of masculinity and body impact, feelings of stigmatisation and social isolation, and the importance of a supportive relationship for wellbeing. Another27 revealed significant negative associations between infertility distress and self-esteem, mental health, and relationship satisfaction. The third study29 identified no symptoms of depression among participating men but found that over 30% presented with anxiety.

Healthy habits

Two studies (1.9%) were concerned with exploring healthy habits among women experiencing infertility. One study30 examined levels of compliance with cervical screening, status of rubella immunity, and folic acid supplementation in women beginning In-Vitro Fertilisation (IVF). Overall, poor levels of compliance were observed. The other study31 was focused on folic acid specifically and found that although 64% of participating women were aware of recommendations, only 58% understood these and only 26% were compliant.

Success rates of ART

Thirty-three studies (31.4%) were concerned with ART success rates. These studies were typically outputs from ICMART or ESHRE. The Irish success rates reported varied from year to year. Delivery rates for IVF were as low as 18.6%32 and as high as 39.5%33 per transfer. For Intracytoplasmic Sperm Injection (ICSI), delivery rates were as low as 18.8%32 and as high as 38.3%34 per transfer. For frozen embryo transfers (FETs), delivery rates were as low as 7.9%35 and as high as 30.5%33. The number of Irish clinics returning data varied from as low as 1 clinic up to 6 clinics year-on-year. Not all papers categorised as focusing on success rates were outputs from ICMART or ESHRE. For example, Geisler and colleagues36 reported on the outcomes, and predictors of these, from 851 couples undergoing Intrauterine Insemination (IUI). They reported lower age and multiparity as predictors of success, and a cumulative pregnancy rate of 34.9% over three IUI cycles.

Risks associated with ART

Four studies (3.8%) focused on the risks associated with ART. Two37,38 assessed for differences in the outcomes of twin pregnancies conceived via ART and those spontaneously conceived, and found no significant differences. Another study39 compared IVF and spontaneous pregnancies and identified higher rates of miscarriage and pregnancy complications among the IVF group. The final study40 examined birth weight and multiple births among ART pregnancies as compared to spontaneous pregnancies and found that multiple births and low birth weight were more common41 for ART pregnancies, particularly in the case of multiple births.

Alternative and supplemental treatments

Five (4.8%) studies considered the use of alternative and supplemental treatments to ART. Two studies42 evaluated restorative reproductive medicine for couples experiencing infertility, with one reporting a live birth rate of 18.4% across 403 couples within 24 months of treatment and the other reporting a live birth rate of 25.5% within 24 months. Other studies explored the impact of other procedures including myomectomy43 and the use of bromocriptine in hyperprolactinaemic women44. The final study45 examined the prevalence of herbal medication usage among women availing of ART.

Gamete quality and ovarian reserve

Three studies (2.9%) considered gamete quality or ovarian reserve. One study46 compared semen samples during treatment to those collected during initial testing and found a significant increase in sperm motility on the day of oocyte recovery. Two studies47,48 explored anti-müllerian hormone (AMH) levels in infertile populations offering a mean AMH level (17.86 pmol/L47 and 18.87 pmol/L48) and reporting a decrease in mean AMH of 1.72 pmol/L per year47.

Causes of infertility

Two studies (1.9%) focused on causes of infertility. O’Driscoll et al.49 explored the causes of infertility for 50 Irish couples in the 1950s and identified male factor infertility as the cause in 20% of cases, tubal factors in 38% of cases, ovarian causes in 16% of cases and psychological and miscellaneous factors in 12% of cases. Skrabanek and colleagues50 assessed the frequency with which hyperprolactinaemia was identified among patients being investigated for reproductive and endocrine disorders.

Service description and evaluation

Thirteen studies (12.4%) focused on service description and evaluation. They typically described the initiation of a new service and outcomes or experiences during the early months. Examples included a joint gynaecology and urology clinic established at St James’s Hospital51 and a fully outpatient-based, self-financing, IVF service established in the Rotunda Hospital52. Other papers described the early use of particular infertility treatments in Ireland such as ICSI53, testicular sperm extraction54, or dual anonymous gamete donation55.

Ethics, access, and organisation of care

Nine studies (8.6%) considered a variety of issues pertaining to ethics, access, and organisation of infertility care. Three studies5658 considered ART legislation in Ireland, with one57 examining how its absence impacts patients’ experiences and another58 engaging healthcare providers regarding draft legislation. One study59 considered cost of, and access to, ART, reporting an average cost of 5,400e per ART cycle in Ireland. Another study60 considered additional hidden costs of IVF, reporting that these increased with additional distance from the fertility clinic with accommodation costs particularly significant. Two studies61 considered the impact of COVID on ART provision, with one61 exploring patients’ reactions to risk mitigation strategies and pregnancy advice and the other62 profiling the impact on services nationally as compared to other countries. One study63 engaged fertility patients regarding their attitudes to, and opinions around, donor activity within ART. The last study64 examined the characteristics of patients who “abandoned” frozen embryos.

Quality of service provision

Three studies (2.9%) focused on the quality of service provision experienced by fertility patients. One study65 explored the source and transmission of microorganisms during IVF and found 50% of cycles had microorganisms grown in any fluid culture but patient outcomes were independent of microbial presence. Another66 examined patient satisfaction with pharmacy services provided during ART. It identified an overall pharmacy complaint rate of 11.8%, with problems being reported more frequently in relation to community pharmacies rather than specialty pharmacies. The final study67 explored how the clinic setting contributes to patients’ experiences, and involved the assessment of two fertility clinics across variables such as privacy available and friendliness of staff.

Optimising treatment regimes or protocols

Twelve studies (11.4%) examined potential means of optimising ART treatment regimes or protocols. These studies explored various changes to treatment protocols such as varied exogenous luteinizing hormone (LH) dosages68, fresh versus frozen embryo transfer69, the use of culture medium versus saline solution for follicular flushing during oocyte retrieval70, the duration of gonadotropin stimulation71, and single versus double embryo transfer72. The impact of these modifications varied; for instance, higher LH dosages were significantly associated with implantation rates but not with live birth rates68; cumulative pregnancy rate was similar with both single and double embryo transfer72 and for fresh and frozen embryo transfers69; there was no impact of duration of gonadotropin stimulation on clinical pregnancy rates in IVF71, and; pregnancy rates were similar whether culture medium or saline solution were used for follicular flushing70. Other studies looked at treatment protocols beyond IVF. For instance, Oduola et al.73 compared the outcomes of ovulation induction via timed sexual intercourse (TSI) or IUI for ovulatory women versus anovulatory women and different ovulation induction regimens.

Exploring factors that may predict treatment outcomes

Ten studies (9.5%) explored factors that might predict ART outcomes. Factors assessed included lifestyle and demographic factors (e.g., alcohol intake)74, physical factors (e.g., uterine dimension)74, biochemical factors (e.g., ovarian reserve)74, uterine natural killer cells75, vitamin D status76, age77,78, serum oestradiol per oocyte ratio79, previous IVF failures, and metabolomics analysis of follicular fluid80. Factors that were identified as being predictive of treatment outcomes were markers of ovarian reserve74, uterine natural killer cell populations75, age77,78, characteristics of follicular fluid80, and serum oestradiol per oocyte ratio79. One study81 explored predictors of spontaneous conception in patients with a prior successful ART pregnancy and identified younger age, shorter infertility duration, unexplained infertility, and endometriosis as predictors.

Discussion

This review has demonstrated a substantive body of research (>100 studies, published 1951 to 2023) exists on infertility in RoI, with a marked growth in the number of publications since 2010. The extent of the research literature is perhaps surprising given RoI’s poor performance on metrics relating to infertility care2. The increasing focus on infertility research reflects the increasing burden of infertility observed internationally82. The synthesis undertaken allows us to offer an evaluation of the existing body of infertility research in the RoI as well as to offer recommendations for future research. Understanding the research activity in this area is important for facilitating clinical practice and care delivery as research can yield an understanding of variables crucial to the provision of high-quality care (e.g., treatment efficacy, patient experience) and engagement in research by clinicians and organisations is associated with improved healthcare performance12,13.

Although the body of research identified is relatively sizable- to offer a comparison, a scoping review of patient safety research from RoI83 identified 31 papers, a scoping review of perinatal mental health research from RoI84 identified 29 papers- it is still limited in many respects. First, a significant proportion is focused solely on reporting ART success rates and is led by international researchers. While such papers offer valuable insights into the outcomes of ART services in RoI, and facilitate international comparison (e.g., in the most recent ESHRE report a pregnancy rate of 27.7% per IVF transfer was observed in Ireland as compared to a high of 50.5% of IVF transfers resulting in pregnancies in Lithuania and a low of 21.1% of IVF transfers resulting in pregnancy in Greece)15, they may not reflect research activity or interest from RoI researchers. These papers also do not consider within-country variation or change over time. Second, our review identified a very limited number of qualitative studies. There are many aspects of infertility likely to be best considered via qualitative research such as the ‘illness’ experience of persons of persons experiencing infertility and the patient experience of treatment services85. Qualitative health research considers “the perspective of the people themselves, rather than the researcher’s perspective”86, which emphasises its importance to truly understanding a condition and advancing care. Next, the RoI literature demonstrates limited engagement with healthcare providers (1.9% of studies) and few studies explore experiences, or quality, of service provision (2.9% of studies). Given that infertility care in RoI is provided in the absence of legislation and, until late 2023, by private service providers only, engaging healthcare providers and exploring quality of care seems imperative. The synthesis offered herein may valuably stimulate future research to advance our understanding of these important aspects of infertility within RoI.

Infertility-related research priorities have been established internationally22,23. Duffy and colleagues23 have offered priority research questions which are largely clinical in nature and focused primarily on establishing optimal protocols and testing procedures for persons experiencing infertility. Contributing to addressing such research questions will require more concentrated research activity within the themes of optimising treatment regimes and protocols, exploring factors that may predict treatment outcomes, and ethics, access, and organisation of care in RoI as well as internationally. The research priorities articulated by García and colleagues22 were used to support the coding of studies undertaken in the current review. Our synthesis reveals a dearth of research relating to the safety of treatments, coping with infertility, impact of diet, healthy habits, impact of exercise, and risks associated with ART. Research priorities are intended to support funder decision-making and to promote the conduct of research that is useful23. It is therefore crucial that researchers in the RoI and internationally are cognisant of these established priorities, and that as state-funded infertility services are rolled out that provision is made to allow researchers access in order to support research that may yield improved care and better understanding of infertility. Finally, there is precedent for national-level research priority setting exercises87,88. Given the RoI’s unique context in relation to infertility, such an exercise might be recommended. Use of the Priority Setting Partnership approach of the James Lind Alliance89, with a strong emphasis on patient and carer involvement, could be appropriate. This will ensure that, in addition to contributing to the international infertility research agenda, that research is conducted to assist with the implementation of high quality state-funded infertility services and appropriate protections for, and support of, persons experiencing infertility.

Limitations

There are a number of limitations to our review which should be noted. First, there was a small number (n=8) of potentially relevant articles for which we were unable to access full-texts. We must therefore acknowledge the possibility that some relevant articles that should have been included were not. Second, we did not assess the quality of the included studies. This is typical for scoping reviews90, and is a recognised limitation. Third, no stakeholder engagement was undertaken as part of the current review. A stakeholder consultation phase is considered optional within scoping reviews91 but may contribute to contextualising the data and determining the recommendations to result from the review. We have suggested a national priority setting exercise, and the data from the current review might usefully guide stakeholders within this process.

Suggestions for future international comparative research

Our review has offered a clear overview of the current infertility research landscape in RoI, the identification of research gaps, and clarity regarding how research has addressed recognised infertility research priorities. It may therefore be recommended that similar reviews consider research outputs on infertility in other countries, or more widely across Europe in order to identify intra-country differences and commonalities. We can find no similar national reviews of infertility research. There continues to be substantial variability in availability of ART services across Europe and in ART pregnancy and delivery rates15. Such data convey the necessity of understanding and advancing research within individual countries, contexts, and health systems as well as internationally. Scoping reviews can offer significant value for stimulating research in individual countries and might facilitate important country-to-country comparisons.

Suggestions for future Irish research

As RoI begins to introduce state-funded ART9, it will be important that researchers prepare to evaluate the implementation of these services, including consideration of patient and provider experience and clinical outcomes. Further, RoI continues to lack ART legislation and a national registry of ART activity. As the country progresses towards instituting these, it will be crucial that researchers explore their impact on practices, outcomes, and patient experiences. Finally, it is notable that so few of the included studies considered the quality or safety of infertility care. Healthcare quality and safety has emerged as a key priority of health research92, and is particularly relevant within the provision of care by private service providers and in the absence of legislation. Accordingly, future research that comprehensively assesses the quality and safety of infertility care is imperative.

Conclusion

We have synthesised over 70 years of research on infertility conducted in the RoI and used this amalgamation of information to make recommendations for future research to improve infertility services and to showcase the extent of engagement in infertility research by clinicians and organisations in the country. This scoping review may offer a useful model for synthesising and planning infertility research in other countries. In Ireland, the understanding of existing “local” research is crucial as state-funded infertility services are introduced and may usefully encourage and support both future research and provision of high-quality care.

Ethics and consent

Ethical approval and consent were not required.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 24 Apr 2024
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
VIEWS
618
 
downloads
68
Citations
CITE
how to cite this article
Earley Á, O'Dea A, Madden C et al. A scoping review of infertility research conducted in the Republic Of Ireland [version 1; peer review: 1 approved]. HRB Open Res 2024, 7:20 (https://doi.org/10.12688/hrbopenres.13877.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 24 Apr 2024
Views
11
Cite
Reviewer Report 16 Sep 2024
David Crosby, Trinity College Dublin, Dublin, Leinster, Ireland 
Ciara Nolan, Department of Reproductive Medicine, Merrion Fertility Clinic and The National Maternity Hospital, Dublin 2, Ireland 
Approved
VIEWS 11
Peer Review Report for the article “A Scoping Review of Infertility Research in the Republic of Ireland.”

Thank you for the opportunity to be a peer reviewer for this comprehensive article on the body of infertility research ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Crosby D and Nolan C. Reviewer Report For: A scoping review of infertility research conducted in the Republic Of Ireland [version 1; peer review: 1 approved]. HRB Open Res 2024, 7:20 (https://doi.org/10.21956/hrbopenres.15214.r39703)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 24 Apr 2024
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions

Are you a HRB-funded researcher?

Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.

You must provide your first name
You must provide your last name
You must provide a valid email address
You must provide an institution.

Thank you!

We'll keep you updated on any major new updates to HRB Open Research

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.